642
Views
0
CrossRef citations to date
0
Altmetric
Immunology

Microsimulation model of the cost-effectiveness of anifrolumab compared to belimumab in the United Arab Emirates

, , &
Pages 23-34 | Received 12 Jan 2024, Accepted 15 Feb 2024, Published online: 11 Mar 2024